Insider Transactions in Q3 2023 at Nurix Therapeutics, Inc. (NRIX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2023
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,884
-5.92%
|
$16,956
$9.65 P/Share
|
|
Jul 31
2023
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,420
-10.17%
|
$12,780
$9.65 P/Share
|
|
Jul 31
2023
|
Hans Van Houte Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,245
-1.49%
|
$11,205
$9.65 P/Share
|
|
Jul 30
2023
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,207
+7.81%
|
-
|
|
Jul 30
2023
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,924
+13.19%
|
-
|
|
Jul 30
2023
|
Hans Van Houte Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,886
+2.87%
|
-
|